Position
BARCLAYS PLC in Collegium Pharmaceutical, Inc
Back to the book · All holders of COLL
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$951.9K$46.30 → $33.07
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2022 | 30.2K | $701.1K | — | — | — | 0.0% |
| Q1 2023 | 34.6K | $831.2K | $23.99 | $23.9K | $106.2K | 0.0% |
| Q2 2023 | 33.9K | $728.1K | $21.49 | −$84.7K | −$18.4K | 0.0% |
| Q3 2023 | 39.6K | $884.9K | $22.35 | $29.1K | $127.7K | 0.0% |
| Q4 2023 | 72.7K | $2.24M | $30.78 | $333.8K | $1.02M | 0.0% |
| Q1 2024 | 47.2K | $1.83M | $38.82 | $379.2K | −$787K | 0.0% |
| Q2 2024 | 29.8K | $958.3K | $32.20 | −$197K | −$675.6K | 0.0% |
| Q3 2024 | 75.1K | $2.9M | $38.64 | $191.7K | $1.75M | 0.0% |
| Q4 2024 | 79.8K | $2.28M | $28.65 | −$749.8K | $134.7K | 0.0% |
| Q1 2025 | 73.7K | $2.2M | $29.85 | $88.4K | −$173.4K | 0.0% |
| Q2 2025 | 89.4K | $2.64M | $29.57 | −$20.6K | $465.2K | 0.0% |
| Q3 2025 | 74K | $2.59M | $34.99 | $401.2K | −$455.5K | 0.0% |
| Q4 2025 | 103.6K | $4.8M | $46.30 | $837.3K | $1.37M | 0.0% |
| Q1 2026 | 71.9K | $2.38M | $33.07 | −$951.9K | −$1.47M | 0.0% |